{
"info": {
"nct_id": "NCT01717391",
"official_title": "Improving Pelvic Cancer Patient Chemoradiotherapy Outcomes With FLT PET Imaging",
"inclusion_criteria": "* Ability to understand and willingness to sign a written informed consent document.\n* Recommended to undergo pelvic irradiation with concurrent chemotherapy.\n* At least 18 years of age. Pediatrics would be best served by a protocol designed for their specific needs.\n* Karnofsky Performance Status of at least 60% at time of screening.\n* Life expectancy of greater than 6 months.\n* Subject must have normal organ and marrow function (as defined below) within 30 days of study enrollment:\n\n * leukocytes at least 3,000 / µL\n * absolute neutrophil count of at least 1500 / µL\n * platelets of at least 100,000 / µL\n * creatinine equal to or less than the upper limit of normal\n* not pregnant (as applicable)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* history of allergic reactions attributed to compounds of similar chemical or biologic composition to FLT\n* an oncology research protocol requiring full pelvic radiation (i.e., 4 field box technique)\n* uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* subjects taking nucleoside analog medications such as those used as antiretroviral agents.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Ability to understand and willingness to sign a written informed consent document.",
"criterions": [
{
"exact_snippets": "Ability to understand",
"criterion": "cognitive ability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "willingness to sign a written informed consent document",
"criterion": "willingness to consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Recommended to undergo pelvic irradiation with concurrent chemotherapy.",
"criterions": [
{
"exact_snippets": "Recommended to undergo pelvic irradiation",
"criterion": "pelvic irradiation",
"requirements": [
{
"requirement_type": "recommendation",
"expected_value": true
}
]
},
{
"exact_snippets": "concurrent chemotherapy",
"criterion": "concurrent chemotherapy",
"requirements": [
{
"requirement_type": "recommendation",
"expected_value": true
}
]
}
]
},
{
"line": "* At least 18 years of age. Pediatrics would be best served by a protocol designed for their specific needs.",
"criterions": [
{
"exact_snippets": "At least 18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Karnofsky Performance Status of at least 60% at time of screening.",
"criterions": [
{
"exact_snippets": "Karnofsky Performance Status of at least 60%",
"criterion": "Karnofsky Performance Status",
"requirements": [
{
"requirement_type": "percentage",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Life expectancy of greater than 6 months.",
"criterions": [
{
"exact_snippets": "Life expectancy of greater than 6 months.",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Subject must have normal organ and marrow function (as defined below) within 30 days of study enrollment:",
"criterions": [
{
"exact_snippets": "normal organ and marrow function",
"criterion": "organ and marrow function",
"requirements": [
{
"requirement_type": "functionality",
"expected_value": "normal"
}
]
}
]
},
{
"line": "* leukocytes at least 3,000 / µL",
"criterions": [
{
"exact_snippets": "leukocytes at least 3,000 / µL",
"criterion": "leukocytes",
"requirements": [
{
"requirement_type": "count",
"expected_value": {
"operator": ">=",
"value": 3000,
"unit": "/ µL"
}
}
]
}
]
},
{
"line": "* absolute neutrophil count of at least 1500 / µL",
"criterions": [
{
"exact_snippets": "absolute neutrophil count of at least 1500 / µL",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "µL"
}
}
]
}
]
},
{
"line": "* platelets of at least 100,000 / µL",
"criterions": [
{
"exact_snippets": "platelets of at least 100,000 / µL",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "/ µL"
}
}
]
}
]
},
{
"line": "* creatinine equal to or less than the upper limit of normal",
"criterions": [
{
"exact_snippets": "creatinine equal to or less than the upper limit of normal",
"criterion": "creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "ULN"
}
}
]
}
]
},
{
"line": "* not pregnant (as applicable)",
"criterions": [
{
"exact_snippets": "not pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* history of allergic reactions attributed to compounds of similar chemical or biologic composition to FLT",
"criterions": [
{
"exact_snippets": "history of allergic reactions attributed to compounds of similar chemical or biologic composition to FLT",
"criterion": "allergic reactions to compounds similar to FLT",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* an oncology research protocol requiring full pelvic radiation (i.e., 4 field box technique)",
"criterions": [
{
"exact_snippets": "full pelvic radiation",
"criterion": "pelvic radiation",
"requirements": [
{
"requirement_type": "technique",
"expected_value": "full"
}
]
},
{
"exact_snippets": "4 field box technique",
"criterion": "radiation technique",
"requirements": [
{
"requirement_type": "specific technique",
"expected_value": "4 field box"
}
]
}
]
},
{
"line": "* uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.",
"criterions": [
{
"exact_snippets": "uncontrolled intercurrent illness including, but not limited to, ongoing or active infection",
"criterion": "intercurrent illness",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "ongoing or active infection",
"criterion": "infection",
"requirements": [
{
"requirement_type": "status",
"expected_value": "ongoing or active"
}
]
},
{
"exact_snippets": "symptomatic congestive heart failure",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "symptoms",
"expected_value": "symptomatic"
}
]
},
{
"exact_snippets": "unstable angina pectoris",
"criterion": "angina pectoris",
"requirements": [
{
"requirement_type": "stability",
"expected_value": "unstable"
}
]
},
{
"exact_snippets": "cardiac arrhythmia",
"criterion": "cardiac arrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
"criterion": "psychiatric illness/social situations",
"requirements": [
{
"requirement_type": "impact on compliance",
"expected_value": "limit compliance with study requirements"
}
]
}
]
},
{
"line": "* subjects taking nucleoside analog medications such as those used as antiretroviral agents.",
"criterions": [
{
"exact_snippets": "subjects taking nucleoside analog medications",
"criterion": "nucleoside analog medication usage",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "such as those used as antiretroviral agents",
"criterion": "antiretroviral agent usage",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}